Valion Bio, Inc.

NasdaqCM:VBIO Stock Report

Market Cap: US$2.1m

Valion Bio Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:VBIO Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
15 Apr 26BuyUS$10,400Sheryle BoltonIndividual10,000US$1.04
01 Apr 26BuyUS$18,008Christina ValauriIndividual19,000US$0.95

Insider Trading Volume

Insider Buying: VBIO insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of VBIO?
Owner TypeNumber of SharesOwnership Percentage
Public Companies61,2051.95%
Individual Insiders73,6892.35%
Institutions472,89915.1%
General Public2,531,30280.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 257.4%.

Top Shareholders

Top 18 shareholders own 19.36% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.41%
3i Fund
107,108US$70.3k0%0.58%
3.24%
Avenue Capital Group, LLC
101,638US$66.7k0%0.61%
2.8%
Geode Capital Management, LLC
87,818US$57.7k4,000%no data
1.95%
Biostax Corp.
61,205US$40.2k0%no data
1.95%
Sanctuary Advisors, LLC
61,205US$40.2k0%no data
1.89%
Marex Group plc
59,263US$38.9k44.8%no data
1.35%
Hudson River Trading LLC
42,419US$27.9k0%no data
1.04%
Jennifer Ernst
32,691US$21.5k0%no data
0.61%
Christina Valauri
19,000US$12.5k0%no data
0.35%
Michael Handley
11,030US$7.2k25%no data
0.33%
XTX Markets Limited
10,506US$6.9k0%no data
0.32%
Sheryle Bolton
10,000US$6.6k0%no data
0.075%
UBS Asset Management AG
2,366US$1.6k-88%no data
0.019%
Tower Research Capital Europe Limited
584US$383.4-64.6%no data
0.017%
Lisa Wolf
526US$345.521.2%no data
0.014%
Kimberly Bambach
442US$290.30%no data
0.00051%
SBI Holdings, Inc.
16US$10.50%no data
0.00003%
Caitong International Asset Management Co., Limited
1US$0.60%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/03 03:55
End of Day Share Price 2026/06/03 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Valion Bio, Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hunter DiamondDiamond Equity Research LLC